Integral now tops PEP fund’s radiology list

MELBOURNE: Private equity’s promised land has caught the eye of Pacific Equity Partners’ Secure Assets… read more
Stellar half drives record Cochlear dividend payout to shareholders

MELBOURNE: Cochlear has declared a record interim dividend, thanks to strong growth for its core… read more
CSL valuation pumping via blood rush despite ozempic effect

MELBOURNE: A casual visitor to the ASX from another universe watching CSL’s valuation shrink in… read more
Neuren Pharma tumbles 14pc on short-seller report

NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed drug licensing… read more